SOLICITATION NOTICE
66 -- UPLC Systems - FDA SOL 1147444
- Notice Date
- 5/14/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA1147444
- Point of Contact
- Telisha Wilson, Phone: 2404027572
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- UPLC Systems Solicitation Number: FDA-SOL-1147444 Subject: Two Ultra Performance Liquid Chromatography (UPLC) Systems with PDA detectors and Operating Software for use in the laboratory PART 1 - DESCRIPTION The U.S. Food and Drug Administration (FDA)'s Center for Drug Evaluation and Research (CDER) has a requirement for Two Ultra Performance Liquid Chromatography Systems with PDA detectors and Operating Software for use in the laboratory. The FDA intends this Request for Quotation (RFQ) to result in the award of a firm-fixed-price purchase order under U.S. General Services Administration (GSA) Schedule 615-9: Liquid Chromatographer (LC) and Liquid Chromatographer/Mass Spectrometer (LC-MS) Systems and Related Chemistries, Supplies and Consumables. PART 2 - SUPPLIES AND SERVICES AND PRICES 2.1 CONTRACT TYPE: FIRM-FIXED-PRICE 2.2 Pricing Table Contract Line Item Number (CLIN) Product and Service Description Price* 0001 Two Ultra Performance Liquid Chromatography Systems $ 1001 Installation and Training $ 2001 Shipping $ $ TOTAL Contract Line Item Number (CLIN) Service Maintenance Price* 0001 Base Option $ 1001 Option Year 1 $ 2001 Option Year 2 $ TOTAL PART 3 - DESCRIPTION/SPECIFICATIONS 3.1 Scope of Work The Food and Drug Administration's Office of Acquisitions and Grants Services has a requirement for Two Ultra Performance Liquid Chromatography (UPLC) Systems with PDA detectors and Operating Software with a two year warranty. The lab system technical requirements: • UPLC Quarternary solvent Manager • UPLC Sample Manager w/Column Manager (supports 4 columns) • UPLC Solvent Tray Module • UPLC e/PDA (Extended Wavelength Photodiode Array) Detector with analytical Cell and Leak Sensor, Range 190nm to 800nm • Performs in-line injections as opposed to loop injections • Operating Software for single system • UPLC System Start Up Kit Service and Maintenance: • All equipment should come with a 2 year total assurance Warranty and 1 Performance Maintenance Visit • 2 year maintenance for the Operating Software • Operating Software must control the equipment, collect, store & evaluate the acquired data and include reporting methods that print the chromatograms, date & evaluations in intelligible form • Installation and Training The Contractor shall provide only newly manufactured parts, not used and refurbished or previously used for demonstration parts. The FDA TPOC will accept and approve all tasks and deliverables. DELIVERY AND INSTALLATION No later than 30 days from the effective date of the order, the Contractor shall deliver all equipment at the delivery address listed below. The Contractor shall fully install all equipment with associated accessories at the place of delivery, including all necessary installation qualification and operation qualification (IQ/OQ) for optimal performance, within 30 days from the effective date of the order. Satisfactory performance of this order includes delivery and acceptance by the TPOC of all equipment. Deliveries required by the Contractor shall be made Freight on Board (FOB) destination to the address listed below: DELIVERY POINT: U.S. Food and Drug Administration Center for Drug Evaluation and Research 4300 River Road College Park, MD 20740 Attention: TPOC, TBD Unless otherwise specified, deliveries shall be made to the Delivery Point specified above, Monday through Friday (excluding Federal Holidays) between the hours of 8:30 a.m. and 5:30 p.m. ET only. Equipment scheduled for delivery on a Federal holiday shall be made the next business day. The Contractor shall provide the TPOC with notice of delivery date and time within a reasonable time prior to the expected delivery of the equipment to help ensure proper delivery. Standard Manufacturer's Warranty The Contractor shall provide a one year standard manufacturer's warranty, which shall cover protection against defects in materials and workmanship and warranty all equipment conforms to the specifications described above, including installation deficiencies. The warranty shall not take effect until the TPOC determines the Contractor has successfully completed delivery and installation of the equipment, and the TPOC received, inspected, and accepted all equipment. The warranty shall include all costs associated with repairs, including parts, labor, and travel. For all on-site maintenance, the Contractor's personnel are required to report to the security guards at 5100 Paint Branch Parkway, College Park, MD 20740, who will contact the TPOC or his designated FDA employee. The Contractor's personnel must be escorted by the TPOC or his designated FDA employee at all times while working on-site under this order. 3.3 Contract Administration The FDA Technical Point of Contact (TPOC) The following TPOC will represent the FDA for the purpose of this order: (To Be Determined Upon Award of Order) The TPOC is responsible for the following: (1) monitoring the Contractor's technical progress, including surveillance and assessment of performance and recommending to the FDA Contracting Officer changes in requirements; (2) interpreting the Statement of Work and any other technical performance requirements; (3) performing technical evaluations; (4) performing technical inspections and acceptances; and (5) assisting in the resolution of technical problems encountered during performance. The Contracting Officer is the only person with authority to act as agent of the Government under this contract. Only the Contracting Officer has authority to direct or negotiate any changes in the task order, including modifying or extending the period of performance, changing the delivery schedule, and authorizing reimbursement to the Contractor for any costs incurred during the performance of their contracts. The contact information for the FDA Contracting Officer is the following: Nicola Carmichael U.S. Food and Drug Administration Office of Acquisitions and Grants Services 5630 Fishers Lane Rockville, MD 20857 Nicola.Carmichael@fda.hhs.gov Telephone: (240) 402-7568 The contact information for the FDA Contract Specialist is the following: Telisha Wilson U.S. Food and Drug Administration Office of Acquisitions and Grants Services 5630 Fishers Lane Rockville, MD 20857 Telisha.Wilson@fda.hhs.gov Telephone: (240) 402-7572 The contact information for the Contractor is the following: [TBD] 3.4 Payment and Invoicing The Government will pay the Contractor only for the firm-fixed-prices delineated in the pricing table in Subpart 2.2 above and only upon successful completion of the CLIN, including delivery and acceptance of all deliverables, as determined by the TPOC, and upon submission of a proper invoice. Proper invoice submission includes following the invoice instructions below. Invoicing Instructions The Contractor shall submit all invoices in the manner specified below: The Contractor shall submit one original copy of each invoice to the address specified below: Office of Financial Services U.S. Food and Drug Administration 10903 New Hampshire Avenue W032-Second Floor Building 32, Room 2162, Mail Hub 2145 Silver Spring MD 20993-0002 Attn: Vendor Payments Phone: (301) 827-3742 or (866) 807-3742 Email: fdavendorpaymentsteam@fda.gov Invoices submitted under this order must comply with the requirements set forth in FAR 52.232-33 (Payment by Electronic Funds Transfer- System for Award Management (SAM) (Jul 2013)) and the other applicable FAR clauses specified herein. To constitute a proper invoice, the invoice must be submitted on Contractor letterhead and include each of the following: (I) Name and address of the Contractor; (II) Invoice date and invoice number; (III) Order number; (IV) Description, quantity, unit of measure, unit price, and extended price of supplies delivered or services performed, including: (a) period of performance for which costs are claimed; (b) itemized travel costs, including origin and destination; and (c) any other supporting information necessary to clarify questionable expenditures; (V) Shipping number and date of shipping, including the bill of lading number and weight of shipment if shipped on government bill of lading; (VI) Terms of any discount for prompt payment offered; (VII) Name and address of official to whom payment is to be sent (must be the same as that in the order or in a proper notice of assignment); (VIII) Name, title and phone number of person to notify in event of a defective invoice; (IX) Taxpayer Identification Number (TIN); (X) Electronic Funds Transfer (EFT) banking information, including routing transit number of the financial institution receiving payment and the number of the account into which funds are to be deposited; (XI) Name and telephone number of the FDA TPOC; and, (XII) Any other information or documentation required by the order. Questions regarding invoices shall be directed to the FDA's Office of Financial Services at the telephone numbers provided above. Payment will only be made on a firm-fixed-price basis. 3.5 HHSAR Clauses Incorporated by Reference This order incorporates the following U.S. Department of Health and Human Services Acquisition Regulation (HHSAR) clauses by reference with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at the following website: http://www.hhs.gov/policies/hhsar/. 352.203-70, Anti-Lobbying (January 2006) 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010) 352.231-71, Pricing of adjustments (January 2001) 3.6 CONFLICTS OF INTEREST The Contractor shall warrant that, to the best of its knowledge and belief, and except as otherwise disclosed in its quote, it does not have any actual, potential, or apparent conflict of interests pertaining to the subject procurement, as described in FAR Subpart 9.5 and HHS and FDA policies, for its organization, employees, or subcontractors proposed to be working under procurement. After award of an order for this procurement, if the Contractor discovers an actual, potential, or apparent conflict of interest with respect to this procurement, it shall make an immediate and full disclosure in writing to the FDA Contracting Officer and TPOC for this order, including a description of any actions the Contractor has taken or proposes to take to avoid, neutralize, or mitigate any conflict of interest. The Contractor shall act impartially and objectively and must avoid actions that would cause a reasonable person to question their impartiality or engage in activities that may result in an unfair competitive advantage. The Government reserves the right to exercise any remedy available at law or equity, including termination of the order for cause or convenience, should the Government determine remedial action is necessary to address any actual, potential, or apparent conflict of interest. Contractors shall include a clause substantially similar to this conflicts of interest clause in any subcontract. PART 4 - INSTRUCTIONS TO OFFERORS Cover Page Offerors shall include a cover page which shall include the following: • Point of contact (name, telephone number, and email address), • Refer to RFQ in the subject line as "FDA-RFQ-1146250" • Estimated delivery date of all equipment, • Business size and type (e.g. small, 8(a) small businesses, veteran-owned small businesses, woman-owned small businesses, etc.), • Dun and Bradstreet (DUNS) number, • GSA contract number, • Country where equipment is manufactured, • Certification that all offeror information listed in the SAM and GSA websites are complete, accurate, and current, and • Affirmation of the lack of conflicts of interest or information related to any actual, potential, or apparent conflicts of interest which may affect the offeror's ability to perform this requirement in an impartial and objective manner or that may result in an unfair competitive advantage in accordance with the Conflicts of Interest terms in Section 3. Offerors Response Date and Time All quotes and revisions shall be submitted via email to Telisha.Wilson@fda.hhs.gov by or before 9:00 AM Eastern Time on Friday, May 10, 2015. NOTE: LATE QUOTES WILL NOT BE EVALUATED. FAR PROVISIONS INCORPORATED BY REFERENCE FAR 52.252-1, Solicitation Provisions Incorporated by Reference (February 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: http://www.acquisition.gov/far/ FAR 52.212-1, Instructions to Offerors - Commercial Items (April 2014), applies to this acquisition and is incorporated by referenced. Please pay special attention to 52.212-1(b)(3-7) to ensure the FDA has sufficient information to determine whether an offer is technically acceptable to perform this requirement delineated above. FAR 52.217-5, Evaluation of Options (July 1990) Offerors shall prepare their quotes pursuant to the terms and condition of their applicable GSA Schedule contract and demonstrate they have the necessary technical capabilities to complete the requirement delineated above. Offerors are encouraged to provide discounts below their GSA maximum rates for this competitive procurement. The FDA will evaluate quotes and make an award decision based on the lowest evaluated price meeting or exceeding the technical acceptability standards delineated above.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA1147444/listing.html)
- Record
- SN03731192-W 20150516/150514235040-b969c0baa287b097ea0d06d1aca894ae (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |